What is CPC Pathology?
CPC Pathology offers comprehensive pathology services, distinguished by its team of board-certified and subspecialty-certified pathologists possessing over two decades of experience in both anatomic and clinical pathology. The company is accredited by the College of American Pathologists and adheres to Clinical Laboratory Improvement Amendments standards, signifying its commitment to exceptional quality. CPC Pathology prioritizes personalized service and rapid turnaround times, ensuring efficient communication and accessibility for a diverse clientele, including medical offices and various healthcare providers. Their dedication to superior customer service and diagnostic accuracy sets them apart within the independent laboratory market.
How much funding has CPC Pathology raised?
CPC Pathology has raised a total of $644K across 1 funding round:
Debt
$644K
Debt (2021): $644K with participation from PPP
Key Investors in CPC Pathology
PPP
Public-Private Partnership
What's next for CPC Pathology?
The recent major strategic investment in CPC Pathology signals a pivotal moment for the company, likely enabling further scaling of its operations and enhancement of its diagnostic capabilities. This infusion of capital is expected to support strategic initiatives aimed at expanding market reach and potentially integrating advanced technologies into their service offerings. CPC Pathology's focus on quality and personalized service, combined with this new financial impetus, positions it for continued growth and leadership in the competitive pathology services landscape.
See full CPC Pathology company page
